Delegate Wachsman presented HB 2649, describing it as an update to the prescription monitoring program (PMP) reporting rules. He said the bill targets a federal exemption that had left substance‑abuse clinics exempt from reporting dispensings on the PMP and noted Illinois had removed a similar exemption.

He explained the bill reminds substance‑abuse clinics they must obtain patient authorization where required by federal law and that the measure includes a delayed effective date so clinics can obtain software needed to submit data. The sponsor said the change would allow pharmacists and physicians checking the PMP to see controlled‑substance dispensings recorded by substance‑abuse clinics.

No witnesses appeared in opposition in the heard record. The subcommittee voted to report HB 2649 6–0; the transcript records the motion, second and the outcome but no roll‑call names.